Opioid Induced Constipation Treatment Market Will be Worth US$4.8 bn by 2023 by Metcarl · January 17 Mattias Ekholm Olympics Jersey , 2019
Global Opioid Induced Constipation Treatment Market: Snapshot
There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over the recent past, but the continuous approval rate of highly targeted drugs is expected to provide a strong push to this market鈥檚 growth rate. This includes the PAMORA drugs that help treat OIC without intervening in the opioid鈥檚 action on the patient.
View Report-
The number of patients suffering from opioid induced constipation is increasing across the globe. Close to 100 mn U.S. patients in 2013 were suffering from OIC, according to the American Academy of Pain Medicine. They added that this number is expected to increase as the number of people consuming opioid drugs increases. With a growing awareness of the commercial availability of a large variety of opioid drugs Jacob Markstrom Olympics Jersey , people have resorted to using them for longer terms to treat chronic pains. This growing number of OIC patients 鈥?especially in North America 鈥?is expected to further drive the demand for opioid induced constipation treatment.
There is, however, the competition that opioid induced constipation treatment providers face from standard laxatives. Most healthcare organizations still consider standard laxatives as the first line of treatment for OIC. Additionally, the long term adverse effects of opioid induced constipation treatments have not completely been documented.
All in all Henrik Lundqvist Olympics Jersey , the global market for opioid induced constipation treatment is expected to be valued at US$731.2 mn by the end of 2016. Owing to a whopping CAGR of 31.2% from 2015 to 2023, this revenue is expected to reach US$4.8 bn by 2023.
Request A Sample-
;rep_id=6862
North America Consumption of OIC Treatment Trumps Other Regions
North America has always taken up a large chunk of the global consumption of opioid induced constipation treatment drugs. By the end of 2023, North America alone is expected to generate US$4.05 bn of the global revenue from opioid induced constipation treatments. This region also leads in terms of growth rate of demand, owing to the large percentage of population that consumes opioid drugs and suffers from OIC. This comes from a high number of patients that are suffering from chronic diseases and are resorting to opioids.
Additionally Robin Lehner Olympics Jersey , the penetration of opioid induced constipation treatments is very low in other regions as compared to North America. This could be the reason for the high disparity of consumption rates between regions. At the moment, North America dominates in terms of opioid consumption. According to the ASIPP, the U.S. alone consumes close to 80% of the global supply of opioids.
Mu-opioid Receptor Antagonists to Overtake Chloride Channel Activators by 2023
Till the end of 2016, chloride channel activators are expected to be the more popular drug class of opioid induced constipation treatments. This trend will continue for the coming years Alexander Steen Sweden Jersey , but in time it is predicted that mu-opioid receptor antagonists will take the leading role among drug classes. A key reason for the popularity of chloride channel activators is the high level of sales of Amitiza ever since it was approved in 2013 and used specifically for opioid induced constipation treatment.
Request Brochure-
;rep_id=6862
Over time, the growing number of mu-opioid receptor antagonists being approved and their greater efficacy over other drug classes is expected to push it to the top of the charts in terms of revenue generation before 2023. This drug class will also benefit from the increasing number of prescriptions being filed for opioid induced constipation treatments due to developments that reduce their side effects.
The leading providers of opioid induced constipation treatment include AstraZeneca, Takeda Pharmaceutical Company Limited, Abbott Laboratories Henrik Zetterberg Sweden Jersey , Valeant, Bayer, C.B. Fleet Company, Inc. Rickard Rakell Sweden Jersey , Boehringer Ingelheim, Daewoong Co. Ltd., and Cosmo Pharmaceuticals.
Home Theater Installation Made Easy Home Repair Articles | April 9, 2011 Most of us love going to movies Carl Soderberg Sweden Jersey , but very few of us love paying the astronomical fees for admission and popcorn. This is why many people are opting to invest their hard-earned dollars into equipme...
Most of us love going to movies, but very few of us love paying the astronomical fees for admission and popcorn. This is why many people are opting to invest their hard-earned dollars into equipment they can install in their home. Creating a comfortable environment for watching movies that has great picture and great sound can be achieved with proper home theater installation. This guide will help review a few of the things you should keep in mind when preparing for your home theater installation.
Bartagamen Züchter Forum
Thema drucken
07.12.2019 10:13
Antworten
